登入選單
返回Google圖書搜尋
其他書名
New Perspectives
出版2022
URLhttp://books.google.com.hk/books?id=ZfQb0AEACAAJ&hl=&source=gbs_api
註釋Alzheimer,Äôs disease (AD) was defined as a neurodegenerative disorder, being more affected in the elderly. It is estimated that every 3.2¬†seconds a person in the world is affected by the high disease that rate in 2050 to 1¬†second. Therefore, research has been carried out on new therapeutic approaches, such as Transcranial Photobiomodulation and treatment based on antioxidants, such as Resveratrol. Therefore, the objective is to conduct a literature review on these two approaches and their effects on the treatment of AD. It was carried out according to the PRISMA recommendation and the articles were selected according to the years of publication (between 2015 and 2020) and extracted from the following databases: Science Direct, PubMed PMC, Scopus, PubMed NCBI, SciELO, LILACS, MEDLINE and PEDro. In several studies it has been reported that both therapies provide improvements at the molecular and behavioral level, recovering brain functions, acting in a neuroprotective way, improving quality of life, with few adverse effects and in a less invasive way. Thus, both treatments have numerous benefits that can be useful in the treatment of AD. However, there is a need for further research that includes interventions with greater specificity and control, so that they are defined as ideal doses and treatment protocols.